40.40 - 41.05
29.80 - 47.18
2.12M / 3.68M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
110.84%
Net income growth under 50% of CRK's 634.04%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
15.43%
Less D&A growth vs. CRK's 788.39%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
240.46%
Well above CRK's 327.47% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
16.67%
SBC growth well above CRK's 7.76%. Michael Burry would flag major dilution risk vs. competitor’s approach.
163.53%
Well above CRK's 202.20% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
133.37%
AR growth well above CRK's 20.40%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-100.00%
Both reduce yoy inventory, with CRK at -100.00%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-100.00%
Negative yoy AP while CRK is 149.63%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
119.78%
Some yoy usage while CRK is negative at -93.45%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
8632.93%
Some yoy increase while CRK is negative at -310.98%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
44.87%
Operating cash flow growth below 50% of CRK's 222.49%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
24.89%
CapEx growth well above CRK's 2.59%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
234.68%
Acquisition growth of 234.68% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-696.59%
Both yoy lines negative, with CRK at -627.24%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
15.20%
We have mild expansions while CRK is negative at -1.29%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-15084.57%
Both yoy lines negative, with CRK at -50.00%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
No Data
No Data available this quarter, please select a different quarter.
-17.78%
We cut yoy buybacks while CRK is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.